Skip to content

V-cares

Active
Private limited companyfounded 20215 yrs activeMaaswinkelstraat 2, 3520 Zonhoven, BelgiumKBO/BCE: BE 0766.262.782

The computed 12-month bankruptcy probability of V-cares is 1.8% (moderate). The 2024 annual accounts show equity of €357k and a net result of €192k. Equity is growing by ~87.5% per year across the filed fiscal years. Its solvency ranks better than 53% of 26048 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
66 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability93▲+12
Solvency61▲+19
Growth78=
Track record94
Bankruptcy probability, 12 months
1.8% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €23k at 30 days acceptable
Liquidity short (current ratio 0.66 against 0.51 in 2023; short-term debt: 17.4% and cash: 9.8% of total assets), and 64.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 5 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 08-07-2025, 23 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
not confirmed
2024
23 d early
2023
9 d early
2022
31 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity
€357k▲ 116%
2023 · €165k
2022: €68k 2023: €165k
2022 → 2024
Total assets
€1.00M▲ 0.3%
2023 · €998k
2022: €257k 2023: €998k
2022 → 2024
Net result
€192k▲ 93.2%
2023 · €99k
2022: €59k 2023: €99k
2022 → 2024
Working capital
€-60k▲ 54.2%
2023 · €-130k
2022: €-27k 2023: €-130k
2022 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line202220232024Trend
Equity€68k-€165k▲ 144%€357k▲ 116%
Operating result€85k-€154k▲ 80.6%€220k▲ 43.2%
Net result€59k-€99k▲ 67.2%€192k▲ 93.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2022: €85k€85kNet result 2022: €59k€59kOperating result 2023: €154k€154kNet result 2023: €99k€99kOperating result 2024: €220k€220kNet result 2024: €192k€192k202220232024
The operating result has risen two years in a row; 2024 is 43% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.00M
Fixed assets €887k▲ 2.9%
Current assets €114k▼ 16.1%
Equity and liabilities €1.00M
Equity €357k▲ 116%
Debt €644k▼ 22.7%
The debt ratio falls from 83.4% to 64.3%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€220k
2023 · €154k
Cash flow
€192k
2023 · €99k
Solvency
35.7%
2023 · 16.6%
Current ratio
0.66
2023 · 0.51
Quick ratio
0.66
2023 · 0.51
Debt / equity
1.80
2023 · 5.03
ROE
53.7%
2023 · 60.0%
ROA
19.2%
2023 · 9.9%
Interest coverage
9.95
2023 · 7.97
Debt
€644k
2023 · €833k
Debt ≤ 1 year
€174k
2023 · €266k
Debt > 1 year
€470k
2023 · €567k
Income taxes
€51k
2023 · €35k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€998k€1.00M
Fixed assets21/28€862k€887k
Tangible fixed assets22/27€532€339
Furniture and vehicles24€532€339
Financial fixed assets28€862k€887k
Current assets29/58€136k€114k
Amounts receivable within one year40/41-€16k
Other amounts receivable41-€16k
Cash at bank and in hand54/58€135k€98k
Deferred charges and accrued income490/1€660€474
Equity and liabilities
Total equity and liabilities10/49€998k€1.00M
Equity10/15€165k€357k
Contributions10/11€10k€10k=
Reserves13€155k€347k
Distributable reserves133€155k€347k
Amounts payable17/49€833k€644k
Amounts payable after more than one year17€567k€470k
Financial debts170/4€567k€470k
Amounts payable within one year42/48€266k€174k
Current portion of amounts payable after more than one year42€45k€47k
Trade debts44€639€168
Suppliers440/4€639€168
Taxes, remuneration and social security45€18k€4k
Taxes450/3€17k€4k
Remuneration and social security454/9€1k-
Other amounts payable47/48€202k€123k
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€48€193
Other operating charges640/8€528€952
Gross operating margin9900€154k€221k
Operating profit (loss)9901€154k€220k
Financial income75/76B-€45k
Recurring financial income75-€45k
Financial charges65/66B€19k€22k
Recurring financial charges65€19k€22k
Profit (loss) for the period before taxes9903€134k€243k
Income taxes67/77€35k€51k
Profit (loss) for the period9904€99k€192k
Profit (loss) for the period to be appropriated9905€99k€192k
Appropriation of the result
Profit (loss) to be appropriated9906€99k€192k
Transfer to equity691/2€98k€192k
To other reserves6921€98k€192k
Profit to be distributed694/7€2k-
Return on contributions (dividend)694€2k-

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
08-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2022net €192k ▲93.2%
Operating result €220k, net result €192k, both a record.
31-12
Financial Equity above €200kEq €357k ▲116%
3 profitable years in a row build equity to €357k.
22-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Equity above €150kEq €165k ▲144%
2 profitable years in a row build equity to €165k.
30-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zonhoven · 1 establishment unit since 2021
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Maaswinkelstraat 23520 Zonhoven
Ground area
743 m²
Building footprint
225 m²
Volume, LiDAR
1,116 m³
Parcel 71443E1038/00F002, Flanders · tallest building 9.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
V-cares
Maaswinkelstraat 2, 3520 ZonhovenRetail sale of pharmaceutical products
since 20212.315.329.424
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71443E1038/00F002 Flanders 743 m² 1 · 225 m² 9.1 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,462 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded01-04-2021
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
70200Business and other management consultancy
70220Business consulting
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.